Volume 73, Issue 8, Pages (April 2008)

Slides:



Advertisements
Similar presentations
Aim To determine the effects of a Coversyl- based blood pressure lowering regimen on the risk of recurrent stroke among patients with a history of stroke.
Advertisements

Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Mortality and Cardiovascular Events Are Best Predicted.
Date of download: 7/1/2016 From: Time-Updated Systolic Blood Pressure and the Progression of Chronic Kidney Disease: A Cohort Study Ann Intern Med. 2015;162(4):
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Usual Blood Pressure and Risk of New-Onset Diabetes:
Dr John Cox Diabetes in Primary Care Conference Cork
Volume 82, Issue 12, Pages (December 2012)
The SPRINT Research Group
Copyright © 2014 American Medical Association. All rights reserved.
Hypertension in the Post SPRINT era
Copyright © 2015 American Medical Association. All rights reserved.
Blood Pressure and Age in Controlling Hypertension
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Copyright © 2011 American Medical Association. All rights reserved.
Volume 81, Issue 5, Pages (March 2012)
Copyright © 2007 American Medical Association. All rights reserved.
Systolic Blood Pressure Intervention Trial (SPRINT)
Progress and Promise in RAAS Blockade
Abdominal obesity modifies the risk of hypertriglyceridemia for all-cause and cardiovascular mortality in hemodialysis patients  Maurizio Postorino, Carmen.
Volume 375, Issue 9709, Pages (January 2010)
Determinants of new onset diabetes among hypertensive patients randomised in the ASCOT-BPLA Trial Dr Ajay K Gupta International Centre for Circulatory.
Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure  Steven Fishbane, Nobuyuki Miyawaki  Kidney International 
Apolipoprotein E-containing high-density lipoprotein (HDL) modifies the impact of cholesterol-overloaded HDL on incident coronary heart disease risk:
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
High prevalence of chronic kidney disease in Thailand
Volume 79, Issue 12, Pages (June 2011)
Volume 93, Issue 1, Pages (January 2018)
Prehypertension and chronic kidney disease: the ox or the plow?
Incidence of all renal events according to achieved BP levels, adjusted for age, gender, duration of diabetes, glycosylated hemoglobin, currently treated.
Volume 82, Issue 12, Pages (December 2012)
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies 
Higher systolic blood pressure is associated with progression of carotid intima–media thickness in patients with chronic kidney disease  Jessica Kendrick,
Volume 86, Issue 4, Pages (October 2014)
Need for better diabetes treatment for improved renal outcome
Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD  Rachael L. Morton, PhD, Iryna Schlackow, DPhil, Natalie Staplin, PhD, Alastair.
Figure 1 Diagram showing analysis flow of patient selection and treatment allocation of ONTARGET/TRANSCEND. Figure 1 Diagram showing analysis flow of patient.
Volume 81, Issue 3, Pages (February 2012)
Volume 79, Issue 12, Pages (June 2011)
Volume 93, Issue 1, Pages (January 2018)
Vitality Measured as Self-reported Energy Level and Clinical Outcomes in Hemodialysis Patients: The Japanese Dialysis Outcomes and Practice Pattern Study.
C.Y. Hsu, J.D. Ordoñez, G.M. Chertow, D. Fan, C.E. McCulloch, A.S. Go 
Volume 76, Issue 10, Pages (November 2009)
Volume 84, Issue 5, Pages (November 2013)
Volume 82, Issue 3, Pages (August 2012)
Volume 77, Issue 7, Pages (April 2010)
Jennifer E. Flythe, Stephen E. Kimmel, Steven M. Brunelli 
Volume 74, Issue 9, Pages (November 2008)
Volume 81, Issue 5, Pages (March 2012)
Volume 86, Issue 3, Pages (September 2014)
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Baseline Characteristics of the Subjects*
Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney.
Methods for guideline development
Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease  C.P. Kovesdy, S. Ahmadzadeh,
Volume 85, Issue 5, Pages (May 2014)
Carmine Zoccali, Francesca Mallamaci  Kidney International 
Volume 83, Issue 3, Pages (March 2013)
Volume 60, Issue 3, Pages (September 2001)
Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm
Volume 75, Issue 1, Pages (January 2009)
Importance of blood pressure control in hemodialysis patient survival
Associations between type of MI and incident HF
Volume 63, Pages S13-S16 (February 2003)
Vitamin D deficiency and anemia in early chronic kidney disease
Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes  Steven M. Brunelli, Ravi Thadhani,
Volume 81, Issue 11, Pages (June 2012)
Volume 71, Issue 7, Pages (April 2007)
Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients  M.R. Marshall, B.G. Byrne, P.G. Kerr,
Longitudinal relationships between diet-dependent renal acid load and blood pressure development in healthy children  Danika Krupp, Lijie Shi, Thomas.
Friends, social networks, and progressive chronic kidney disease
Effect of randomized treatment on all renal events (top) and the composite of all renal events, macrovascular events, or all-cause mortality (bottom) according.
Presentation transcript:

Volume 73, Issue 8, Pages 963-970 (April 2008) Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial  T. Ninomiya, V. Perkovic, M. Gallagher, M. Jardine, A. Cass, H. Arima, C. Anderson, B. Neal, M. Woodward, T. Omae, S. MacMahon, J. Chalmers  Kidney International  Volume 73, Issue 8, Pages 963-970 (April 2008) DOI: 10.1038/ki.2008.5 Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 1 Effects of randomized treatment on the risk of stroke according to baseline systolic or diastolic blood pressure levels in patients with and without chronic kidney disease. Treatment effects in subgroup were standardized for the proportions of the study population for whom combination (58%) or single-drug therapy (42%) was prescribed by taking weighted averages of the estimates obtained for the two therapies. Solid boxes represent estimates of treatment effect on the risk of clinical outcomes. Centers of the boxes are placed at the estimates of effect; areas of the boxes are proportional to the number of events. Horizontal lines represent 95% CI. Vertical broken lines represent point estimates for overall effects. The ‘P trend’ tested the consistency of the treatment effect in CKD and non-CKD subgroups. SBP/DBP difference indicates the mean reduction in SBP or DBP produced by randomized treatment. CKD, chronic kidney disease; CI, confidence interval; DBP, diastolic blood pressure; SBP, systolic blood pressure. Kidney International 2008 73, 963-970DOI: (10.1038/ki.2008.5) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 2 Effects of randomized treatment on the risk of subtype of stroke according to baseline systolic or diastolic blood pressure levels in participants with chronic kidney disease. Conventions as for Figure 1. Kidney International 2008 73, 963-970DOI: (10.1038/ki.2008.5) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 3 Age- and sex-adjusted incidence rates or multivariate-adjusted hazard ratios of total stroke according to achieved follow-up systolic or diastolic blood pressure levels. Solid boxes or open boxes represent the estimates of incidence rates or hazard ratios of total stroke according to the presence or absence of CKD, respectively. Centers of the boxes are placed at the estimates of incidence rate or hazard ratios; areas of the boxes are proportional on the number of events. Vertical lines represent 95% confidence intervals. Boxes offset from each other for clarify. The hazard ratios were estimated using time-dependent Cox's proportional hazards model that contained dummy variables for CKD and BP levels and potential confounding factors (baseline age, sex, smoking, diabetes, body mass index, study treatment, and combination therapy). The reference group is participants with CKD and SBP 120–139 mm Hg. The trends of the relationship of achieved follow-up BP levels with events were tested by kidney function status. CKD, chronic kidney disease; CI, confidence interval. Kidney International 2008 73, 963-970DOI: (10.1038/ki.2008.5) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 4 Age- and sex-adjusted incidence rates of ischemic and hemorrhagic stroke according to achieved follow-up systolic or diastolic blood pressure levels. Conventions as for Figure 3. Kidney International 2008 73, 963-970DOI: (10.1038/ki.2008.5) Copyright © 2008 International Society of Nephrology Terms and Conditions